title: Baseline antiretroviral resistance and clinical outcomes in an urban HIV clinic.
authors.forename: Olga M
authors.initials: OM
authors.lastname: Klibanov
authors.forename: Christian R
authors.initials: CR
authors.lastname: Dolder
authors.forename: Ferealem
authors.initials: F
authors.lastname: Assefa
authors.forename: Tagbo J
authors.initials: TJ
authors.lastname: Ekwonu
mesh_terms: D000328:Adult; D000554:Ambulatory Care Facilities; D044966:Anti-Retroviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D024882:Drug Resistance, Viral / Q000235:genetics*; D005260:Female; D006678:HIV / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009154:Mutation; D009657:North Carolina / Q000453:epidemiology; D015995:Prevalence; D012194:RNA-Directed DNA Polymerase / Q000235:genetics; D012044:Regression Analysis; D012189:Retrospective Studies; D012959:Socioeconomic Factors; D016896:Treatment Outcome; D014505:Urban Population
chemical_list: D044966:Anti-Retroviral Agents; D012194:RNA-Directed DNA Polymerase